LindaMarieBavisottoMD

Clinical Trials

• Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas Start of enrollment: 2010 May 01

  Active, not recruiting

  Phase 1

• Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions Start of enrollment: 2007 Aug 01

  Completed

  Not Applicable

• Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions Start of enrollment: 2007 Sep 01

  Completed

  Not Applicable

• Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer Start of enrollment: 2011 Mar 01

  Unknown status

  Phase 1

• A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia Start of enrollment: 2013 Dec 01

  Completed

  Phase 1

• Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies Start of enrollment: 2014 Jul 01

  Completed

  Phase 1, Phase 2

• ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2015 May 01

  Completed

  Phase 2

• Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer Start of enrollment: 2015 May 01

  Completed

  Phase 2

• Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell Carcinoma Start of enrollment: 2015 May 01

  Completed

  Phase 2

• A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL Start of enrollment: 2017 Feb 02

  Active, not recruiting

  Phase 3

• A Study Evaluating MM-310 in Patients With Solid Tumors Start of enrollment: 2017 Feb 22

  Unknown status

  Phase 1

• Join now to see all